Determinants of Antigenicity and Immunogenicity

Download as pdf or txt
Download as pdf or txt
You are on page 1of 20

Determinants of antigenicity and

immunogenicity
Molecular entities recognized by lymphocytes

• Antigen: any molecule that is specifically recognized by an antibody


or a T-cell receptor (TCR)

• Immunogen: the type of antigen that evokes an adaptive immune


response

• Hapten: a non-immunogenic molecule (often with low molecular


weight) that can be made immunogenic by conjugation to a suitable
carrier
• Epitope: the portion of an antigen that is
recognized and bound by an Ab or TCR
(antigenic determinant) Epitope
interacts with
paratope
• Paratope: The site of an antibody or a TCR that
binds to an epitope on an antigen
The B cell is the one that is going
to be linked if the hapten is
conjugated with a protein carrier
NO2

NO2 =

Dinitrophenyl (DNP) hapten

Large protein (carrier)

Immunization Induction of Antibodies

DNP No

Protein-conjugated DNP Yes


What Determines Immunogenicity of an Antigen?
type of ag that
1. Properties of the Immunogen evokes an
adaptive inmune
response

2. Properties of the Host


a. Genetic :
- Antigen presentation (MHC)
- Genes encoding antigen receptors
- Genes Coding for Immune Regulation
b. Physiological: Condition of the Host

3. Mode of Antigen Exposure


1. Contribution of the immunogen to immunogenicity

• Nature of the antigen: type of molecule


Ab  Humoral: proteins >polysaccharides>>>>lipids>nucleic acids
T cell  Cellular: proteins and some lipids

• Features of the immunogen:

 Foreignness
 Molecular size
 Chemical composition and complexity
 Ability to be processed and presented by a MHC molecule
1. Contribution of the immunogen to immunogenicity
The more different the
BSA: Bovine serum albumin animal is, the more
probabable is to develope an
inmune reponse

• Foreignness

- +
• Molecular size: The best immunogens tend to
have a molecular mass approaching 100,000
daltons (Da) The higer the size, the higuer
posibility to find a T epitope

• Chemical composition and heterogeneity

Synthetic homopolymers, containing a single Aa


or a sugar, poor immunogenicity regardless the
size.
The addition of aromatic Aa, (Tyr, Phe) enhances
immunogenicity

• Ability to be processed and presented by a


MHC molecule
1. Contribution of the immunogen to immunogenicity
Levels of protein organization

All four levels contributes to structural complexity of a protein and hence


affects its immunogenicity.
1. Contribution of the immunogen to immunogenicity
Susceptibility to antigen processing and presentation

What is seen by T lymphocytes in an Ag? Ag/MHC

La primera proteína se tiene que


degradar y luego unirse al MHC.

Degradación Unión al MHC

Major histocompatibility complex


molecules
2. Contribution of the host to immunogenicity

MHC = MLA
• Genotype of the host: antigen presentation by MHC products
Algunas personas cuando les vacunan
de Hepatitis B, generan Ab. Otras no lo
hacen. Depende de la genética

PROCESSING
PRESENTATION

Antigen Presentation
processing by MHC molecules

MHC: THE MOST


MHC coge un trozo de algo malo de dentro de la
POLIMORPHIC
célula. Se pone en la membrana con el trozo
MOLECULE IN THE BODY
para que un linfocito pueda ver si es algo malo y
MHC is a hapten because
comérselo.
without the union of the
peptide is not inmunogenic
2. Contribution of the host to immunogenicity

• Genotype of the host: antigen receptors

Individual A

Individual B

• Genes coding for immune regulation

• Physiological condition of the host: immune competence (genetic deficiencies,


disease, therapies….)
3. Contribution of the biological system to immunogenicity:
Mode of antigen exposure

• Immunogen dosage and route of administration


o Insufficient dosage to induce an immune response
o Too much dosage: induction of tolerance (unresponsive state)

Route of administration:
o Oral
o Intradermal
o Subcutaneous
o Intramuscular
o Intraperitoneal
o Intravenous
3. Contribution of the biological system to immunogenicity:
Mode of antigen exposure-adjuvants

• Adjuvants Helpers

o Immune stimulants:
 ↑ co-stimulatory signals
 lymphocyte proliferation

o Vehicle depot: Depósito de vehículos


 ↑ prolong antigen persistence
 Targeting to APC
NO ENTRA
Epitopes
Immunologically active regions of an antigen that bind to antigen-specific membrane
receptors on lymphocytes or to secreted antibodies

• Properties of B-cell epitopes recognised by ab


• Properties of T-cell epitopes recognised by MHC

Ig + Ag TCR + Ag + MHC
Properties of B-cell epitopes

Size: no larger than the size of the


antibody-binding site

Chemical properties: generally


hydrophilic amino acids (exposed on the
protein surface and topographically
accessible to antibodies

Location on Ags: sequential or non-


sequential amino acids
In flexible regions of an immunogen
and displaying site mobility

Conformation: Antibodies
recognize epitopes in native
conformation
not T cells, that
can be
recognized
linear peptides
Properties of B-cell epitopes
Sequence-based methods
for prediction of linear epitopes

 Protein hydrophobicity – hydrophilicity algorithms ALGORITHMS


- Hydrophilicity
 Protein flexibility prediction algorithm - Flexibility
- Secondary
structure
 Protein secondary structure prediction algorithms - Antigenicity

 Protein “antigenicity” prediction

TSQDLSVFPLASCCKDNIASTSVTLGCLVTG
YLPMSTTVTWDTGSLNKNVTTFPTTFHETY
GLHSIVSQVTASGKWAKQRFTCSVAHAEST
AINKTFSACALNFIPPTVKLFHSSCNPVGDT
HTTIQLLCLISGYVPGDMEVIWLVDGQKATN
IFPYTAPGTKEGNVTSTHSELNITQGEWVSQ
KTYTCQVTYQGFTFKDEARKCSESDPRGVT
SYLSPPSPL
Posible epitope
location

Kyte & Doolittle hydropathy plot of


Hopp & Woods antigenicity plot of Alcohol
Alcohol Dehydrogenase
Dehydrogenase. The regions with the highest
values are the most hydrophilic and indicate
potential epitope locations for antigens
Properties of T-cell epitopes

• T cells recognize antigens previously


processed into antigenic peptides that bind
to MHC molecules

• Prediction algorithms based on these


properties
Ag are previously processed so
T cells can recognize them and
bind them to MHC molecules
Applications of antigenicity and immunogenicity
characterization
• Diseño de vacunas y optimización:
-Preparación de vacunas mejoradas.
• Herramientas para monitorear respuestas inmunes
adaptativas:
• Vaccine design
-Perfil deland optimization
estado inmune de individuos y pacientes.
o Preparation
-Monitoreoofdel
improved vaccines
efecto de los tratamientos asociados con IR.
• Generación de anticuerpos contra los depósitos deseados:
-Anticuerpos terapéuticos.
• Tools for -Anticuerpos
monitoring adaptive
para immune
aplicaciones técnicas.responses
o Profiling
• Diseñoofdeimmune
drogas: status of individuals and patients
-Preparación de medicamentos no inmunogénicos.
o Monitoring the effect of treatments associated wit IR

• Generation of antibodies against desired epitopes


o Therapeutic antibodies
o Antibodies for technical applications

• Drug design
o Preparation of non-immunogenic drugs

You might also like